Ada Menaker
VP of Investor Relations and Corporate Development
Replay available
Innoviz Technologies Ltd. (NASDAQ: INVZ) Q3 2025 earnings conference call, held 2025-11-12. Replay captured from the company's public earnings webcast.

VP of Investor Relations and Corporate Development
CEO, Volkswagen Autonomous Driving Mobility and Transport Group (ADMT)
Chief Financial Officer
Chief Executive Officer
Analyst, TD Cowen
Analyst, Goldman Sachs
Analyst, Oppenheimer
Ladies and gentlemen, thank you for standing by. Our call will begin shortly. Ladies and gentlemen, thank you for standing by. Our call will begin shortly. Ladies and gentlemen, thank you for standing by and welcome to Innoviz's third quarter 2025 earnings call. Our presentation today will be followed by a Q&A session, at which time, if you wish to ask a question, you will need to either raise your hand using your mobile or desktop application or press star nine on your telephone keypad and wait for your name to be announced. I must advise you that the call is being recorded today. I'd now like to hand over the call to our first speaker today, Ada Menaker, VP of investor relations and corporate development. Ada, please go ahead. I would like to welcome you to the Innovis Technologies 3rd Quarter 2025 Earnings Conference Call. Joining us today are Omer Kelaf, Chief Executive Officer and Eldar Tsegla, Chief Financial Officer. I would like to remind everyone that this call is being recorded and will be available in the investor relations section of our website at ir.innovis.tech. Before we begin, I would like to remind you that our discussion today will include forward-looking statements that are subject to risks and uncertainties relating to future events and the future financial performance of Innovis. Actual results could differ materially from those anticipated in the forward-looking statements. Forward-looking statements made today speak only to our expectations as of today, and we undertake no obligation to publicly update or revise them. For discussion of some important risk factors that would cause actual results to differ materially from any forward-looking statements, please see the risk factors section of our Form 20-F filed with the SEC on March 12, 2025. Ma...